Effect of age on vascular β2-adrenergic receptor desensitization is not mediated by the receptor coupling to Gαi proteins

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 9, 2006, Pages 899-906

  Schutzer, William E ^a,b   Xue, Hong ^a   Reed, John F ^a   Mader, Scott L ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA; ISOPRENALINE; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

AGE; AGING; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; VASODILATATION;

ANIMALIA;

EID: 33748757940     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.9.899     Document Type: Article

References (48)

1. Schutzer WE, Mader SL. Age-related changes in adrenergic signaling: clinical and mechanistic implications. Ageing Res Rev. 2003;2:169-190.
2. O'Donnell S, Wanstall J. Beta-1 and beta-2 adrenoceptor-mediated responses in preparations of pulmonary artery and aorta from young and aged rats. J Pharmacol Exp Ther. 1984;228:733-738.
3. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372:231-236.
4. Roth N, Campbell P, Caron M, Lefkowitz R, Lohse M. Comparative rates of desensitization of beta-adrenergic receptors by the beta-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1991;88:6201-6204.
5. Scarpace PJ, Abrass IB. Beta-adrenergic agonist-mediated desensitization in senescent rats. Mech Ageing Dev. 1986;35:255-264.
6. Gurdal H, Friedman E, Johnson M. β-adrenoceptor-Gαs coupling decreases with age in rat aorta. Mol Pharmacol. 1995;47:772-778.
7. Daaka Y, Luttrell DK, Lefkowitz RJ. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature. 1997;390:88-91.
8. Xiao RP. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Sci STKE. 2001;2001:RE15.
9. Lefkowitz RJ, Pierce KL, Luttrell LM. Dancing with different partners: protein kinase A phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol Pharmacol. 2002;62:971-974.
10. Tepe NM, Liggett SB. Functional receptor coupling to Gi is a mechanism of agonist-promoted desensitization of the β2-adrenergic receptor. J Recept Signal Transduct Res. 2000;20:75-85.
11. Deisher TA, Mankani S, Hoffman BB. Role of cyclic AMP-dependent protein kinase in the diminished beta-adrenergic responsiveness of vascular smooth muscle with increasing age. J Pharmacol Exp Ther. 1989;249:812-819.
12. Mader SL, Downing CL, Amos-Landgraf J, Swebjka P. Age-related changes in G proteins in rat aorta. J Gerontol Biol Sci. 1996;51A:B111-B116.
13. Johnson MD, Zhou Y, Friedman E, Roberts J. Expression of G-protein-alpha subunits in the aging cardiovascular system. J Gerontol Biol Sci. 1995;50A:B14-B19.
14. 2 expression, resulting in enhanced coupling to G protein-coupled receptors. J Biol Chem. 2002;277:31257-31262.
15. Chapman J, Schutzer WE, Watts VJ, Mader SL. Impaired cholera toxin relaxation with age in rat aorta. J Gerontol Biol Sci. 1999;54A: B154-B159.
16. Fujii K, Onaka U, Goto K, Abe I, Fujishima M. Impaired isoproterenol-induced hyperpolarization in isolated mesenteric arteries of aged rats. Hypertension. 1999;34:222-228.
17. Miller VM, Flavahan NA, Vanhoutte PM. Pertussis toxin reduces endothelium-dependent and independent responses to alpha-2- adrenergic stimulation in systemic canine arteries and veins. J Pharmacol Exp Ther. 1991;257:290-293.
18. Sato K, Komaru T, Shioiri H, et al. Vasodilator signals from the ischemic myocardium are transduced to the coronary vascular wall by pertussis toxin-sensitive G proteins: a new experimental method for the analysis of the interaction between the myocardium and coronary vessels. J Am Coll Cardiol. 2002;39:1859-1865.
19. Petitcolin MA, Vandeputte C, Spitzbarth-Regrigny E, Bueb JL, Capdeville-Atkinson C, Tschirhart E. Lack of involvement of pertussis toxin-sensitive G-proteins in norepinephrine-induced vasoconstriction of rat aorta smooth muscle. Biochem Pharmacol. 2001;61:485-491.
20. Hayes JS, Wyss VL, Schenck KS, Cohen ML. Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists. J Pharmacol Exp Ther. 1986;237:757-763.
21. Vleeming W, van Rooij HH, Wemer J, Porsius AJ. Modulation of adrenoceptor-mediated cardiovascular effects by short-term in vivo infusion of isoproterenol in rats. J Cardiovasc Pharmacol. 1990;16:584-593.
22. Fleisch JH, Titus E. The prevention of isoproterenol desensitization and isoproterenol reversal. J Pharmacol Exp Ther. 1972;181:425-433.
23. Martin SW, Broadley KJ. Relative resistance of functional beta2-adrenoceptor-mediated smooth muscle responses to in vitro desensitization. Can J Physiol Pharmacol. 1999;77:156-165.
24. Gaballa MA, Eckhart AD, Koch WJ, Goldman S. Vascular β-adrenergic receptor adenylyl cyclase system in maturation and aging. J Mol Cell Cardiol. 2000;32:1745-1755.
25. Mader SL. Influence of animal age on the beta-adrenergic system in cultured rat aortic and mesenteric artery smooth muscle cells. J Gerontol Biol Sci. 1992;42A:B32-B36.
26. Lakatta EG. Catecholamines and cardiovascular function in aging. Endocrinol Metab Clin North Am. 1987;16:877-891.
27. Cizza G, Pacak K, Kvetnansky R, et al. Decreased stress responsivity of central and peripheral catecholaminergic systems in aged 344/N Fischer rats. J Clin Invest. 1995;95:1217-1224.
28. McCarty R. Effects of 2-deoxyglucose on plasma catecholamines in adult and aged rats. Neurobiol Aging. 1984;5:285-289.
29. McCarty R. Sympathetic-adrenal medullary and cardiovascular responses to acute cold stress in adult and aged rats. J Auton Nerv Syst. 1985;12:15-22.
30. Petrie EC, Peskind ER, Dobie DJ, Veith RC, Raskind MA. Increased plasma norepinephrine response to yohimbine in elderly men. J Gerontol Med Sci. 2000;55A:M155-M159.
31. Scarpace PJ, Tumer N, Mader SL. β-adrenergic function in aging. Basic mechanisms and clinical implications. Drugs Aging. 1991;1:116-129.
32. Xiao RP, Ji X, Lakatta EG. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 1995;47:322-329.
33. Zamah AM, Delahunty M, Luttrell LM, Lefkowitz RJ. Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system. J Biol Chem. 2002;277:31249-31256.
34. Chin JH, Hiremath AN, Hoffman BB. cAMP signaling mechanisms with aging in rats. Mech Ageing Dev. 1996;86:11-26.
35. Tsujimoto G, Lee CH, Hoffman BB. Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation. J Pharmacol Exp Ther. 1986;239:411-415.
36. Schutzer WE, Watts VJ, Chapman J, et al. Viral-mediated gene delivery of constitutively activated Gas alters vasoreactivity. Clin Exp Pharmacol Physiol. 2000;27:9-13.
37. Mader SL, Alley PA. Age-related changes in adenylyl cyclase activity in rat aorta membranes. Mech Ageing Dev. 1998;101:111-118.
38. Clark RB, Rich TC. Probing the roles of protein kinases in G-protein-coupled receptor desensitization. Mol Pharmacol. 2003;64:1015-1017.
39. 2- adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol. 2004;65:196-206.
40. Seibold A, Williams B, Huang ZF, et al. Localization of the sites mediating desensitization of the beta 2-adrenergic receptor by the GRK pathway. Mol Pharmacol. 2000;58:1162-1173.
41. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by β-arrestins. Science. 2005;308:512-517.
42. Schutzer WE, Reed JF, Bliziotes M, Mader SL. Upregulation of G protein-linked receptor kinases with advancing age in rat aorta. Am J Physiol. 2001;280:R897-R903.
43. Carman CV, Lisanti MP, Benovic JL. Regulation of G-protein receptor kinases by caveolin. J Biol Chem. 1999;274:8858-8864.
44. Schwencke C, Okumura S, Yamamoto M, Geng YJ, Ishikawa Y. Colocalization of β-adrenergic receptors and caveolin within the plasma membrane. J Cell Biochem. 1999;75:64-72.
45. Schutzer WE, Reed JF, Mader SL. Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2005;288:H2457-H2464.
46. Streeten DH, Anderson GH Jr. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens. 1996:9:760-769.
47. Smirnov VN, Voyno-Yasenetskaya TA, Antonov AS, et al. Vascular signal transduction and atherosclerosis. Ann N Y Acad Sci. 1990;598:167-181.
48. Tumer N, Scarpace PJ, Lowenthal DT. Geriatric pharmacology: basic and clinical considerations. Ann Rev Pharmacol Toxicol. 1992;32:271-302.